Advertisement

Search Results

Advertisement



Article Topics

Your search for Michael T. Schweizer, MD, and Daniel W. Lin, MD matches 1 pages

Showing 1 - 1


prostate cancer

Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer: Delaying Overt Metastatic Disease Is a Major Advance

Nonmetastatic (M0) castration-resistant prostate cancer arises in the subset of men with biochemically recurrent disease (ie, rising prostate-specific antigen [PSA] level after definitive therapy in the absence of metastases) who develop PSA progression after chronic exposure to...

Advertisement

Advertisement



Advertisement